Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Targeted Radioligand Therapy: Physics and Biology, Internal Dosimetry and Other Practical Aspects During 177Lu/225Ac Treatment in Neuroendocrine Tumors and Metastatic Prostate Cancer
Safura Jokar

Assistant Professor of Nuclear Pharmacy

Department Nuclear Pharmacy

School of Pharmacy

Tehran University of Medical Sciences

Related Documents
1. Preclinical Study of a New 177Lu-Labeled Somatostatin Receptor Antagonist in Ht-29 Human Colorectal Cancer Cells, Asia Oceania Journal of Nuclear Medicine and Biology (2020)
All Documents
1. Design of a New 99M99mtc-Radiolabeled Cyclo-Peptide As Promising Molecular Imaging Agent of Cxcr4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation, Current Radiopharmaceuticals (2024)
2. Radiolabeling of the Mutant Form of Anti-Plgf Nanobody By99m Tc-Tricarbonyl, Iranian Journal of Pharmaceutical Research (2024)
3. Recent Clinical Implications of Fapi Imaging and Therapy, Clinical Nuclear Medicine (2024)
4. Self-Assembled Peptide/Polymer Hybrid Nanoplatform for Cancer Immunostimulating Therapies, Drug Delivery and Translational Research (2024)
5. Synthesis, Biological Evaluation, and in Silico Study of Novel Coumarin-Quinazoline Analogs As Potential Anti-Angiogenesis Agents, Results in Chemistry (2024)
6. X-Ray-Based Cancer Diagnosis and Treatment Methods, Electromagnetic Waves-Based Cancer Diagnosis and Therapy: Principles and Applications of Nanomaterials (2023)
7. Targeting Caveolin-1 and Claudin-5 With Ay9944, Improve Blood–Brain Barrier Permeability; Computational Simulation and Experimental Study, Cellular and Molecular Neurobiology (2022)
8. The Footprint of Exosomes in the Radiation-Induced Bystander Effects, Bioengineering (2022)
9. Design of Peptide-Based Inhibitor Agent Against Amyloid-Β Aggregation: Molecular Docking, Synthesis and in Vitro Evaluation, Bioorganic Chemistry (2020)
10. Design, Preparation and Biological Evaluation of a 177Lu-Labeled Somatostatin Receptor Antagonist for Targeted Therapy of Neuroendocrine Tumors, Bioorganic Chemistry (2020)
11. Preclinical Study of a New 177Lu-Labeled Somatostatin Receptor Antagonist in Ht-29 Human Colorectal Cancer Cells, Asia Oceania Journal of Nuclear Medicine and Biology (2020)
12. Synthesis, Biological Evaluation and Preclinical Study of a Novel 99Mtc-Peptide: A Targeting Probe of Amyloid-Β Plaques As a Possible Diagnostic Agent for Alzheimer's Disease, Bioorganic Chemistry (2020)
13. Recent Advances in the Design and Applications of Amyloid-Β Peptide Aggregation Inhibitors for Alzheimer’S Disease Therapy, Biophysical Reviews (2019)